期刊文献+

缬沙坦治疗慢性心力衰竭疗效观察 被引量:5

下载PDF
导出
摘要 目的 :观察缬沙坦治疗慢性心力衰竭的临床疗效。方法 :对 90例慢性心力衰竭患者 ,分为对照组、依拉普利组、缬沙坦组 ,依拉普利组在对照组基础上加依拉普利 ,缬沙坦组在对照组基础上加缬沙坦。疗程半年 ,观察治疗前后心超心功能、心率、收缩压、舒张压、ST段下移和NYHA分级情况。结果 :缬沙坦组和依拉普利组较对照组能改善心功能、ST段 ,降低血压等。结论 :缬沙坦能提高慢性心力衰竭的临床疗效 。
出处 《中国交通医学杂志》 2004年第6期664-665,共2页 Chinese Medical JOurnal of Communications
  • 相关文献

参考文献5

  • 1Cheorghiade M, Cody RJ, Francis GS, et al. Current medical therapy for advanced heart failure. Am Heart J 1998; 132:231- 248
  • 2Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995;26:1376-1398
  • 3黄峻.心力衰竭治疗的基石:血管紧张素转换酶抑制剂[J].中华心血管病杂志,2002,30(4):255-257. 被引量:77
  • 4Lang KM, Elkayara U, Yellen LG, et al. Comparative effects of losartan and enaUpril on exercise capacity and clinical status in patient with heart failure. J Am Coll Cardiol 1997;30:983-991
  • 5蔡迺绳,周京敏.血管紧张素Ⅱ受体阻滞剂在心力衰竭治疗中的地位[J].中华心血管病杂志,2002,30(11):702-704. 被引量:50

二级参考文献10

  • 1Hamroff G,Blaufarb I,Mancini D,et al.Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treat with angiotensin-converting enzyme inhibitors for heart failure[].Journal of Cardiovascular Pharmacology.1997
  • 2Krombach RS,Clair MJ,Hendrick JW,et al.Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[].Cardiovascular Research.1998
  • 3Baruch L,Anand I,Cohen IS,et al.Augmented short-and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patient with heart failure[].Circulation.1999
  • 4Lang RM,Elkayam U,Yellen LG,et al.Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure[].Journal of the American College of Cardiology.1997
  • 5McKelvie RA,Yusuf S,Pericak D,et al.Comparison of candesartan,enalapril, and their combination in congestive heart failure[].Circulation.1999
  • 6Hamroff G,Blaufarb I,Mancini D,et al.Maximally recommended doses of ACE inhibitors do not completely prevent ACE-mediated formation of Ang II in CHF[].Circulation.2000
  • 7Dickstein K,Chang P,Willenheimer R,et al.Comparison of the effects of Losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure[].Journal of the American College of Cardiology.1995
  • 8Crozier I,Ikram H,Awan N,et al.Losartan in heart failure:hemodynamic effects and tolerability[].Circulation.1995
  • 9Cohn JN,Tognoni G.A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[].The New England Journal of Medicine.2001
  • 10Havranek EP,Thomas I,Smith WB,et al.Dose-related beneficial longterm hemodynamic and clinical efficacy of irbesartan in heart failure[].Journal of the American College of Cardiology.1999

共引文献120

同被引文献27

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部